TABLE 5.
Microbiological outcomes at TOC visit of ME and MITT patients with MSSA at baseline treated with linezolid or comparator drugsa
Patient population | % of patients cured (no. cured/total) after:
|
|||
---|---|---|---|---|
Treated with linezolid | Randomized to vancomycinb | Receiving vancomycin onlyc | Switched from vancomycin to alternative antibioticd | |
ME | 84.9 (90/106) | 75.3 (70/93) | 77.3 (17/22) | 74.6 (53/71) |
MITT | 73 (92/126) | 66.4 (75/113) | 55.6 (20/36) | 71.4 (55/77) |
TOC visits occured 7 days after the end of treatment.
Patients remained on vacomycin or were switched to an alternative antibiotic.
Patients remained on vancomycin.
Alternative antibiotics specified in the protocol were nafcillin, oxacillin, dicloxacillin, and flucloxacillin.